SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-09-053482
Filing Date
2009-09-04
Accepted
2009-09-04 17:04:44
Documents
6
Period of Report
2009-09-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a09-25532_18k.htm 8-K 60928
2 EX-3.1 a09-25532_1ex3d1.htm EX-3.1 42431
3 EX-4.2 a09-25532_1ex4d2.htm EX-4.2 410684
4 EX-4.3 a09-25532_1ex4d3.htm EX-4.3 52369
5 EX-99.1 a09-25532_1ex99d1.htm EX-99.1 10302
6 GRAPHIC g255321moi001.jpg GRAPHIC 3090
  Complete submission text file 0001104659-09-053482.txt   582799
Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02140
Business Address 100 HAYDEN AVENUE LEXINGTON MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14732 | Film No.: 091056654
SIC: 2835 In Vitro & In Vivo Diagnostic Substances